日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Multi-Center Study of Population Pharmacokinetics of Polymyxin B in Critically Ill Patients

一项关于多粘菌素B在危重患者群体药代动力学的多中心研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S521070
Wang, Yirong; Wang, Xipei; Lei, Liming; Sun, Wanheng; Wu, Zheng; Lan, Jinhua; Chen, Jingchun; Wang, Yifan; Yao, Fen; Hu, Linhui; Bai, Yunpeng; Chen, Chunbo
发表日期：2026
文献求助 收藏

DNA methylation predicts adverse outcomes of coronary artery disease

DNA甲基化可预测冠状动脉疾病的不良预后

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-66204-x
Qin, Min; Tian, Xiaoxue; Wu, Qili; Zhu, Qian; Yu, Meiling; Fang, Xianhong; Chen, Xiaoping; Liu, Chen; Zhang, Bin; Li, Hanping; Wang, Xipei; Pan, Cuiping; Zhong, Shilong
表观遗传
DNA甲基化
发表日期：2025
文献求助 收藏

Population pharmacokinetic analysis of remimazolam after continuous infusion for sedation in critically ill patients

对危重患者持续输注瑞米唑仑进行镇静后的群体药代动力学分析

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1526266
Chen, Jingchun; Wang, Xipei; Chen, Dong; Liu, Xiaolong; Peng, Kaiyi; Tang, Ruizheng; Hu, Linhui; Wang, Yirong; Bai, Yunpeng; Chang, Lin; Chen, Chunbo
发表日期：2025
文献求助 收藏

Optimal Teicoplanin Dosage Regimens in Critically Ill Patients: Population Pharmacokinetics and Dosing Simulations Based on Renal Function and Infection Type

危重患者替考拉宁最佳给药方案：基于肾功能和感染类型的群体药代动力学和剂量模拟

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S413662
Wang, Yifan; Yao, Fen; Chen, Shenglong; Ouyang, Xin; Lan, Jinhua; Wu, Zheng; Wang, Yirong; Chen, Jingchun; Wang, Xipei; Chen, Chunbo
炎症/感染
发表日期：2023
文献求助 收藏

Exploring the causal effects of the gut microbiome on serum lipid levels: A two-sample Mendelian randomization analysis

探索肠道微生物群对血脂水平的因果效应：一项双样本孟德尔随机化分析

期刊:Frontiers in Microbiology
影响因子:4.5
doi:10.3389/fmicb.2023.1113334
Guo, Gongjie; Wu, Yonglin; Liu, Yingjian; Wang, Zixian; Xu, Guifeng; Wang, Xipei; Liang, Feiqing; Lai, Weihua; Xiao, Xiao; Zhu, Qian; Zhong, Shilong
微生物学
发表日期：2023
文献求助 收藏

The Determination of Polymyxin B in Critically Ill Patients by the HPLC-MS/MS Method

采用高效液相色谱-串联质谱法测定危重患者体内多粘菌素B的含量

期刊:International Journal of Analytical Chemistry
影响因子:1.7
doi:10.1155/2023/6674009
Wang, Yirong; Chen, Jingchun; Du, Jinpan; Lei, Liming; Zhao, Boxin; Bai, Yunpeng; Chen, Dong; Wang, Xipei; Chen, Chunbo
发表日期：2023
文献求助 收藏

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication

在健康志愿者和患者中建立文拉法辛和O-去甲基文拉法辛的联合群体药代动力学模型，以评估发病率和合并用药的影响

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.978202
Wang, Zhanzhang; Li, Lu; Huang, Shanqing; Wang, Xipei; Liu, Shujing; Li, Xiaolin; Kong, Wan; Ni, Xiaojia; Zhang, Ming; Huang, Shanshan; Tan, Yaqian; Wen, Yuguan; Shang, Dewei
发表日期：2022
文献求助 收藏

Population Pharmacokinetics of Caspofungin and Dose Simulations in Heart Transplant Recipients

卡泊芬净在心脏移植受者中的群体药代动力学及剂量模拟

期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/aac.02249-21
Wu, Zheng; Lan, Jinhua; Wang, Xipei; Wu, Yijin; Yao, Fen; Wang, Yifan; Zhao, Bo-Xin; Wang, Yirong; Chen, Jingchun; Chen, Chunbo
发表日期：2022
文献求助 收藏

Pharmacokinetics of Linezolid Dose Adjustment for Creatinine Clearance in Critically Ill Patients: A Multicenter, Prospective, Open-Label, Observational Study

利奈唑胺剂量调整对危重患者肌酐清除率的药代动力学影响：一项多中心、前瞻性、开放标签、观察性研究

期刊:Drug Design Development and Therapy
影响因子:5.1
doi:10.2147/DDDT.S303497
Wang, Xipei; Wang, Yifan; Yao, Fen; Chen, Shenglong; Hou, Yating; Zheng, Zhijie; Luo, Jinbiao; Qiu, Binghui; Li, Zhanfu; Wang, Yirong; Wu, Zheng; Lan, Jinhua; Chen, Chunbo
发表日期：2021
文献求助 收藏

Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies

利用群体药代动力学和有限抽样策略评估心脏移植受者体内霉酚酸的暴露量

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2021.748609
Wang, Xipei; Wu, Yijin; Huang, Jinsong; Shan, Songgui; Mai, Mingjie; Zhu, Jiade; Yang, Min; Shang, Dewei; Wu, Zheng; Lan, Jinhua; Zhong, Shilong; Wu, Min
发表日期：2021
文献求助 收藏